
Key information is needed for excipients and their potential impact on continuous manufacturing processes.
David Schoneker is president, Black Diamond Regulatory Consulting, LLC

Key information is needed for excipients and their potential impact on continuous manufacturing processes.

This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.

Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.

Published: February 3rd 2021 | Updated:

Published: August 3rd 2022 | Updated:

Published: June 13th 2024 | Updated: